mFOLFOX6 Standard Dosing Regimen
The standard mFOLFOX6 regimen consists of oxaliplatin 85 mg/m² IV over 2 hours on day 1, leucovorin 400 mg/m² IV over 2 hours on day 1,5-FU 400 mg/m² IV bolus on day 1, followed by 5-FU 2400 mg/m² (1200 mg/m²/day × 2 days) as continuous infusion over 46-48 hours, repeated every 2 weeks. 1, 2
Detailed Dosing Components
Day 1 Administration:
- Oxaliplatin: 85 mg/m² IV infusion over 2 hours
- Leucovorin: 400 mg/m² IV infusion over 2 hours (can be given concurrently with oxaliplatin using Y-connector)
- Alternative: Levoleucovorin 200 mg/m² (equivalent dose) 1
- 5-FU bolus: 400 mg/m² IV push immediately after leucovorin
- 5-FU continuous infusion: 2400 mg/m² over 46-48 hours (1200 mg/m²/day for 2 days)
Cycle Frequency:
Critical Safety Considerations
Order chemotherapy in 24-hour units (1200 mg/m²/day) rather than total dose (2400 mg/m² over 46 hours) to minimize medication errors. This is an explicit NCCN recommendation to prevent potentially fatal dosing mistakes. 1
Clinical Context & Applications
This regimen is used across multiple settings:
- Adjuvant therapy for stage III colon cancer (typically 12 cycles = 6 months) 1
- First-line metastatic disease (alone or with biologics like bevacizumab 5 mg/kg day 1, or panitumumab 6 mg/kg day 1 in RAS wild-type tumors) 2
- High-risk stage II colon cancer 1
Duration Considerations
For adjuvant treatment, recent evidence from the IDEA collaboration suggests that 3 months (6 cycles) may be sufficient for low-risk stage III patients (T1-3, N1), while 6 months (12 cycles) remains standard for high-risk patients (T4 or N2), balancing efficacy against cumulative oxaliplatin neurotoxicity 3. However, this represents a nuanced decision based on individual risk stratification.
Common Pitfalls to Avoid
- Never use bolus 5-FU regimens with oxaliplatin—infusional 5-FU is mandatory for safety and efficacy 1
- Do not confuse with FOLFOX4, which uses different leucovorin dosing (200 mg/m² over 2 hours on days 1 and 2) and different 5-FU administration (400 mg/m² bolus then 600 mg/m² over 22 hours on days 1 and 2) 1
- Ensure adequate hydration and antiemetic prophylaxis
- Monitor for cumulative peripheral neuropathy from oxaliplatin—consider dose reduction or discontinuation if grade 2-3 neuropathy develops